Clinical trial
A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the…
NCT00406848 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00406848 |
|---|---|
| Title | A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients |
| Official title | Duloxetine Versus Placebo in the Long-Term Treatment of Patients With Late-Life Major Depression |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | duloxetine hydrochloride, placebo |
| Enrollment | 370 |
| Start date | Nov 1, 2006 |
| Primary completion | Jul 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Dec 4, 2006 |
| Last update posted | Sep 29, 2010 |
| Countries | France, Mexico, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: